For each experiment, cryopreserved PBMCs were thawed and washed in RP10 medium (RPMI 1640 medium supplemented with 10% FBS plus 2 mM L-glutamine, 100 U/ml penicillin, and 100 U/ml streptomycin). Autologous, untouched naïve T cells and NK cells were purified by negative selection using MACS according to the manufacturer’s instructions. Briefly, T cells were purified using the human Naïve Pan T Cell Isolation Kit (Miltenyi Biotec; CAT# 130-097-095). This kit depletes PBMCs of cells other than naïve T cells using antibodies specific to CD45RO, CD14, CD15, CD16, CD19, CD25, CD34, CD36, CD57, CD123, HLA-DR, CD235a, and CD244 yielding cells that are CD3+CD45RA+CD197+. NK cells were purified using the human NK Cell Isolation Kit (Miltenyi Biotec; CAT#130-092-657). The viability for each cell type was determined using a micro flow cytometer with propidium iodide (Moxi Flow; ORFLO Technologies, Ketchum, ID) or a hemocytometer. MoDCs were pelleted and re-suspended in serum-free RPMI, then plated into wells of a 96-well U-bottom tissue culture treated plate (CELLTREAT, Pepperell, MA) at a seeding density of 2 X 105 cells/200uL/well and 0.5 X 105cells/50uL/well. Cal/09 or Vic/11 was then adsorbed on MoDCs at a multiplicity of infection (MOI) of 3 for 1 h at 37°C and 5% CO2 in FBS-free RPMI. At 1 HPI, virus-containing supernatant was decanted, and MoDCs were either co-cultured with NK cells (1:4 or 4:1 ratios) and/or NK cells and pan naïve T cells (1:1:1, 4:1:1, or 1:4:1 ratios) in serum-containing RP10 medium–which acts to further inhibit viral entry–for the indicated time point (34). NK cells or T cells were stimulated with 162 nM Phorbol-Myristate-Acetate and 2.68 μM ionomycin (PMA/I) for 6 h (NK cells) or 12 h (T cells) for surface marker activation or 4 h for T cell intracellular cytokine staining. MoDCs were stimulated with 30 µg/mL Poly (I:C) for 24 h (In vivogen). In transwell experiments, MoDCs and NK cells were seeded in a 24-well plate and separated during culture by a semipermeable membrane of 0.4-μm pore size (Corning).
Do you have any questions about this protocol?
Post your question to gather feedback from the community. We will also invite the authors of this article to respond.